Mike Kratky
Stock Analyst at Leerink Partners
(4.26)
# 1,364
Out of 4,423 analysts
263
Total ratings
43.7%
Success rate
12.6%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Rated: Hold | $84 → $87 | $87.36 | -0.41% | 31 | Jun 16, 2026 | |
| PRCT PROCEPT BioRobotics | Downgraded: Hold | $65 → $29 | $21.72 | +33.52% | 19 | Jun 12, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $89 → $74 | $45.29 | +63.39% | 8 | May 28, 2026 | |
| SYK Stryker | Initiated Coverage: Buy | $410 | $307.80 | +33.20% | 1 | Apr 13, 2026 | |
| ZBH Zimmer Biomet Holdings | Initiated Coverage: Hold | $101 | $87.97 | +14.81% | 1 | Apr 13, 2026 | |
| PEN Penumbra | Downgraded: Hold | $327 → $374 | $317.20 | +17.91% | 8 | Jan 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $600 | $406.78 | +47.50% | 22 | Oct 22, 2025 | |
| ABT Abbott Laboratories | Reiterated: Hold | $136 | $88.41 | +53.83% | 4 | Oct 16, 2025 | |
| VCEL Vericel | Maintained: Buy | $50 → $48 | $40.10 | +19.70% | 18 | Oct 14, 2025 | |
| DXCM DexCom | Maintained: Buy | $101 → $84 | $72.47 | +15.91% | 21 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $333 → $355 | $145.76 | +143.55% | 15 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $114 | $79.34 | +43.69% | 7 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $29 | $15.30 | +89.54% | 17 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $96 | $42.61 | +125.30% | 28 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $55.30 | - | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $13.88 | +101.73% | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $44.84 | -50.94% | 17 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $15.63 | +15.16% | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $228.39 | n/a | 1 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,098.57 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $46 | $1.16 | n/a | 11 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $31 | $90.43 | n/a | 10 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $16.63 | n/a | 1 | Aug 15, 2022 |
Edwards Lifesciences
Jun 16, 2026
Rated: Hold
Price Target: $84 → $87
Current: $87.36
Upside: -0.41%
PROCEPT BioRobotics
Jun 12, 2026
Downgraded: Hold
Price Target: $65 → $29
Current: $21.72
Upside: +33.52%
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: $89 → $74
Current: $45.29
Upside: +63.39%
Stryker
Apr 13, 2026
Initiated Coverage: Buy
Price Target: $410
Current: $307.80
Upside: +33.20%
Zimmer Biomet Holdings
Apr 13, 2026
Initiated Coverage: Hold
Price Target: $101
Current: $87.97
Upside: +14.81%
Penumbra
Jan 15, 2026
Downgraded: Hold
Price Target: $327 → $374
Current: $317.20
Upside: +17.91%
Intuitive Surgical
Oct 22, 2025
Reiterated: Buy
Price Target: $600
Current: $406.78
Upside: +47.50%
Abbott Laboratories
Oct 16, 2025
Reiterated: Hold
Price Target: $136
Current: $88.41
Upside: +53.83%
Vericel
Oct 14, 2025
Maintained: Buy
Price Target: $50 → $48
Current: $40.10
Upside: +19.70%
DexCom
Oct 14, 2025
Maintained: Buy
Price Target: $101 → $84
Current: $72.47
Upside: +15.91%
Oct 14, 2025
Maintained: Buy
Price Target: $333 → $355
Current: $145.76
Upside: +143.55%
Oct 14, 2025
Maintained: Buy
Price Target: $114
Current: $79.34
Upside: +43.69%
Oct 14, 2025
Maintained: Buy
Price Target: $32 → $29
Current: $15.30
Upside: +89.54%
Oct 14, 2025
Maintained: Hold
Price Target: $96
Current: $42.61
Upside: +125.30%
Oct 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $55.30
Upside: -
Sep 12, 2025
Reiterated: Buy
Price Target: $28
Current: $13.88
Upside: +101.73%
Aug 25, 2025
Maintained: Buy
Price Target: $22
Current: $44.84
Upside: -50.94%
Aug 13, 2025
Reiterated: Buy
Price Target: $17 → $18
Current: $15.63
Upside: +15.16%
Apr 5, 2024
Maintained: Buy
Price Target: n/a
Current: $228.39
Upside: n/a
Oct 16, 2023
Maintained: Buy
Price Target: n/a
Current: $1,098.57
Upside: n/a
Sep 26, 2023
Maintained: Buy
Price Target: $45 → $46
Current: $1.16
Upside: n/a
May 4, 2023
Reiterated: Hold
Price Target: $31
Current: $90.43
Upside: n/a
Aug 15, 2022
Maintained: Buy
Price Target: $40
Current: $16.63
Upside: n/a